Lupin Profit & Loss Annual

BSE: 500257 | NSE: LUPIN | ISIN: INE326A01037 | Sector: Biotechnology & Drugs
1,930.00 -25.35 (-1.30%)Updated : 18 Jul 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 18,599.6417,402.9315,760.0117,799.47
Other Net 195.82-16.85-54.8631.12
Diluted Weighted Average Shares 45.7845.7245.6945.40
Depreciation/ Amortization 1,169.26995.56841.31818.50
Operating Income 4,108.262,607.89881.65-1,393.99
Net Income 3,281.621,914.48430.08-1,528.04
Income Availableto Com Excl Extra Ord 3,281.621,914.48430.08-1,528.04
Other Operating Expenses Total 6,623.93152.92156.81150.84
Net Income Before Taxes 4,015.002,422.27716.49-1,372.21
Minority Interest -24.64-21.09-17.61-18.68
Net Income After Taxes 3,306.261,935.57447.69-1,509.36
Income Availableto Com Incl Extra Ord 3,281.621,914.48430.08-1,528.04
Costof Revenue Total 6,842.257,635.227,702.997,486.11
Gross Profit 15,865.6512,375.608,938.678,919.37
Interest Inc( Exp) Net- Non- Op Total -289.08-169.94-131.28-9.34
Diluted Net Income 3,281.621,914.48430.08-1,528.04
DPS- Common Stock Primary Issue 12.008.004.004.00
Provisionfor Income Taxes 708.74486.70268.80137.15
period Type ----
Net Income Before Extra Items 3,281.621,914.48430.08-1,528.04
Total Revenue 22,707.9020,010.8216,641.6616,405.48
period Length 12.0012.0012.0012.00
Revenue 22,707.9020,010.8216,641.6616,405.48
Selling/ General/ Admin Expenses Total 3,964.208,417.987,019.526,625.43
Diluted Normalized EPS 71.6945.379.665.26
Diluted EPS Excluding Extra Ord Items 71.6941.879.41-33.65
Gain( Loss)on Saleof Assets -1.1720.980.00
Unusual Expense( Income) -201.2539.382,718.59
*All figures in crores except per share values
Recommended For You
Trending Stocks
266.90+6.65(2.56%)
941.85+17.95(1.94%)
162.50+2.65(1.66%)
1,099.10-60.75 (-5.24%)
1,901.05-28.85 (-1.49%)